US Patent 9969811 Pertuzumab variants and evaluation thereof
Patent 9969811 was granted and assigned to Genentech on May, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 19, 2017
Date of Patent
May 15, 2018
Patent Applicant
Patent Application Number
15788574
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9969811 Pertuzumab variants and evaluation thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.